ARAY on Nasdaq
ACCURAY INC
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with MIMEDX GROUP, INC., CryoLife or TACTILE SYSTEMS TECHNOLOGY INC, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Service brought in 57% of the revenue ACCURAY INC broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Service | $212.4M | $220.9M | $229.2M |
| Product | $234.2M | $237.6M | $172.7M |
Regions
Eimea brought in 38% of the revenue ACCURAY INC broke down this way in fiscal 2026.
Regions by year
| Regions | 2024 | 2025 | 2026 |
|---|---|---|---|
| Eimea | $168.6M | $144.3M | $150.9M |
| Americas | $90.2M | $88.8M | $90.0M |
| China | $103.4M | $124.5M | $68.1M |
| Asia Pacific | $28.7M | $47.4M | $48.7M |
| Japan | $55.7M | $53.6M | $44.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue72¢$290.5M
- Research and development9¢$37.8M
- Other costs18¢$71.8M
- Income tax0¢$1.9M
Out of $401.9M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Gross profit | $111.5M | $147.0M |
| Research and development | $37.8M | $47.9M |
| Selling and marketing | $38.6M | $43.3M |
| General and administrative | $45.4M | $47.9M |
| Restructuring | $16.2M | $0 |
| Total operating expenses | $137.9M | $139.1M |
| Income (loss) from operations | -$26.4M | $7.8M |
| Income from equity method investment | $1.1M | $4.7M |
| Interest expense | -$32.9M | -$13.0M |
| Gain on extinguishment of debt | $0 | $1.5M |
| IEEPA refund financing costs | -$2.4M | $0 |
| Gain (loss) from change in fair value of warrant liability | $8.4M | -$499.0K |
| Other income, net | $5.0M | $559.0K |
| Income (loss) before provision for income taxes | -$47.2M | $1.1M |
| Provision for income taxes | $1.9M | $2.7M |
| Net loss | -$49.2M | -$1.6M |
| Net loss per share - basic and diluted (in dollars per share) | -$0.40 | -$0.02 |
| Basic and diluted (in shares) | 122.6M shares | 102.8M shares |
| Unrealized gain from cash flow hedges, net of reclassifications | $1.6M | $0 |
| Foreign currency translation adjustment | -$3.2M | $1.6M |
| Change in defined benefit pension obligation | -$42.0K | $828.0K |
| Comprehensive income (loss) | -$50.9M | $794.0K |
| Revenue from Contract with Customer | $401.9M | $458.5M |
| Cost of Revenue | $290.5M | $311.5M |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2026-06-30 | 2026-03-31 | 2025-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $40.6M | $57.4M | |
| Restricted cash | $611.0K | $574.0K | |
| Accounts Receivable, Allowance for Credit Loss, Current, Net | $67.4M | $83.2M | |
| Inventories | $147.1M | $141.0M | |
| Prepaid expenses and other current assets | $31.8M | $33.5M | |
| Deferred cost of revenue | $276.0K | $1.8M | |
| Total current assets | $287.8M | $317.5M | |
| Property and equipment, net | $27.3M | $28.7M | |
| Carrying value of investment in joint venture | $5.0M | $4.6M | |
| Operating lease right-of-use assets, net | $27.5M | $33.1M | |
| Goodwill | $57.9M | $57.8M | |
| Restricted cash | $7.5M | $4.1M | |
| Other assets | $30.6M | $24.4M | |
| Total assets | $443.7M | $470.2M | |
| Accounts payable | $40.6M | $34.0M | |
| Accrued compensation | $15.7M | $14.6M | |
| Operating lease liabilities | $8.2M | $7.4M | |
| Other accrued liabilities | $32.2M | $29.4M | |
| Customer advances | $10.4M | $12.2M | |
| Deferred revenue, current | $82.8M | $82.8M | $82.3M |
| Short-term debt, net | $1.5M | $12.7M | |
| Total current liabilities | $191.4M | $192.6M | |
| Noncurrent portion of operating lease obligations | $27.8M | $32.5M | |
| Long-term other liabilities | $5.5M | $5.2M | |
| Warrant liability | $2.4M | $8.5M | |
| Deferred revenue, non-current | $28.5M | $28.5M | $26.6M |
| Long-term debt, net | $146.4M | $123.8M | |
| Total liabilities | $402.0M | $389.1M | |
| Common stock, $0.001 par value; authorized: 200,000,000 shares as of June 30, 2026, and June 30, 2025, respectively; 122,541,809 shares issued and 119,433,440 shares outstanding as of June 30, 2026, and 115,752,221 shares issued and 112,643,852 shares outstanding as of June 30, 2025. | $119.0K | $113.0K | |
| Additional paid-in-capital | $613.6M | $602.2M | |
| Accumulated other comprehensive loss | -$3.5M | -$1.8M | |
| Accumulated deficit | -$568.5M | -$519.3M | |
| Total stockholders equity | $41.7M | $81.2M | |
| Total liabilities and stockholders equity | $443.7M | $470.2M | |
| Accounts Receivable, Allowance for Credit Loss, Current | $884.0K | $369.0K | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 200.0M shares | 200.0M shares | |
| Common stock, shares issued (in shares) | 122.5M shares | 115.8M shares | |
| Common stock, shares outstanding (in shares) | 119.4M shares | 112.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2026-06-30 | 2025-06-30 |
|---|---|---|
| Net loss | -$49.2M | -$1.6M |
| Depreciation and amortization | $7.9M | $6.2M |
| Share-based compensation | $6.5M | $10.2M |
| Amortization of debt financing costs and discount for warrants issued to lenders | $8.1M | $1.4M |
| Gain on extinguishment of debt | $0 | -$1.5M |
| Non-cash interest paid-in-kind | $9.7M | $616.0K |
| Gain (loss) from change in fair value of warrant liability | -$8.4M | $499.0K |
| Provision for (recovery of) credit losses | $573.0K | -$101.0K |
| Provision for write-down of inventories | $3.6M | $2.2M |
| Asset Impairments | $2.4M | $0 |
| Loss on disposal of property and equipment | $538.0K | $0 |
| Income from equity method investment | -$1.1M | -$4.7M |
| Net deferred gross profit (loss) on sales to the JV | -$36.0K | $7.7M |
| Provision for deferred income taxes | $624.0K | $156.0K |
| Accounts receivable | $11.5M | $13.4M |
| Inventories | -$12.5M | -$9.1M |
| Prepaid expenses and other assets | -$8.0M | -$2.5M |
| Deferred cost of revenue | $1.5M | -$912.0K |
| Accounts payable | $5.2M | -$18.7M |
| Operating lease liabilities, net of operating lease right-of-use assets | $963.0K | $620.0K |
| Accrued compensation and accrued liabilities | $7.7M | -$5.9M |
| Customer advances | -$1.4M | -$2.4M |
| Deferred revenues | $7.0M | $7.4M |
| Net cash (used in) provided by operating activities | -$7.0M | $2.9M |
| Purchases of property and equipment, net | -$5.9M | -$4.3M |
| Capitalized costs for software to be sold | -$6.4M | -$4.3M |
| Net cash used in investing activities | -$12.3M | -$8.5M |
| Proceeds from the issuance of common stock to employees | $665.0K | $1.6M |
| Taxes paid related to net share settlement of equity awards | -$51.0K | -$90.0K |
| Debt financing costs | -$1.1M | -$13.3M |
| Paydown of 2026 Convertible Notes | -$18.0M | -$68.5M |
| Borrowings under Revolving Credit Facility | $19.0M | $27.0M |
| Repayments under Revolving Credit Facility | -$14.0M | -$37.0M |
| Proceeds from the IEEPA Financing Agreement | $6.6M | $0 |
| Payments of IEEPA refunds to third-party purchaser | -$2.8M | $0 |
| Net cash provided by (used in) financing activities | $7.0M | -$4.3M |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -$1.1M | $1.7M |
| Net decrease in cash, cash equivalents and restricted cash | -$13.4M | -$8.3M |
| Cash paid for income taxes | $2.3M | $3.9M |
| Cash paid for interest | $13.9M | $9.7M |
| Fair value of stock issued to settle Convertible Notes | $0 | $11.1M |
| Fair value of warrants issued with debt | $6.6M | $21.1M |
| Unpaid purchase of property and equipment at end of year | $9.0K | $888.0K |
| Unpaid capitalized software costs at end of year | $0 | $258.0K |
| Transfers from inventory to property and equipment | $1.6M | $3.7M |
| Transfer of inventory to other assets | -$1.2M | $1.2M |
| Transfer of lease liabilities to leasehold improvements | $0 | $1.3M |
| Transfer of other assets to property and equipment | $0 | $242.0K |
| Financing obligation from uncollected IEEPA refunds | $2.8M | $0 |
Recent filings
- Oct 13, 20268-K
- Oct 7, 20263 PRIMARY DOCUMENT
- Oct 7, 20264 PRIMARY DOCUMENT
- Oct 6, 20268-K
- Oct 1, 20264 PRIMARY DOCUMENT
- Sep 18, 2026DEFA14A
- Sep 11, 2026424B3
- Sep 11, 2026EFFECT
- Sep 9, 2026S-3/A
- Sep 2, 20264 OWNERSHIP DOCUMENT
- Sep 2, 2026SCHEDULE 13D/A
- Aug 27, 202610-K
- Aug 24, 2026DEF 14A
- Aug 21, 2026S-3/A
- Aug 19, 20268-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARACCURAY INC filings on SEC EDGAR
- 2SEC EDGARACCURAY INC 10-K for fiscal 2026
- 3SEC EDGARACCURAY INC filings on SEC EDGAR
- 4SEC EDGARACCURAY INC 10-K for fiscal 2019
- 5SEC EDGARACCURAY INC 10-K for fiscal 2020
- 6SEC EDGARACCURAY INC 10-K for fiscal 2021
- 7SEC EDGARACCURAY INC 10-K for fiscal 2022
- 8SEC EDGARACCURAY INC 10-K for fiscal 2024
- 9SEC EDGARACCURAY INC 10-Q for fiscal 2025
- 10SEC EDGARACCURAY INC 10-Q for fiscal 2026
- 11SEC EDGARACCURAY INC 10-K for fiscal 2019